PHIP and colorectal carcinoma: Metagenomes (n = 156) of healthy and CRC patients [25] were screened for gene abundance and contributing taxa of b-gus and gdh. The results provide a mechanistic model of how gut microbiota might influence PhIP disposition and modulate carcinogenesis risk.